Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer This study is currently recruiting participants. Purpose The purpose of this study is to test a new drug called MK-2206 for metastatic colorectal cancer. This drug is being tested in a subgroup of patients with colorectal cancer whose tumors...
Cancer happens genetically when DNA becomes damaged or changed, resulting in a loss of normal cellular growth controls. Other cancers occur during a person’s lifetime due to exposure to chemicals such as cigarette smoke, radiation, and other environmental factors. New technologies are letting scientists to conduct genome-wide searches and look globally for all of...
Colonoscopy is an examination of the lining of the colon and the rectum used screening test for colorectal cancer, because they allow doctors to detect small growths that formed in colorectal tissue and remove them before they turn cancerous. Researchers are looking for ways to improve the accuracy of colonoscopy. The accuracy of colonoscopy...
From 1975 to 2000, the rates of colorectal deaths have declined a lot. We owe it to advances in colorectal cancer screening tests, such as the, flexible sigmoidoscopy, fecal occult blood test and optical (conventional) colonoscopy If we continue at this rate, a 50% reduction in colorectal cancer deaths is possible by 2020. Most...
A nanotechnology-based method is being developed to detect markers predictive of increased colon cancer risk. Colorectal cancers, which attack the colon and rectum, are the second leading cause of cancer death in this country and the third most common cancers among men and women in the United States. Over the past several decades, researchers...